These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2446053)

  • 1. The role of serotonin in cardiovascular disease.
    Frohlich ED
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S1-2. PubMed ID: 2446053
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of serotonin in cardiovascular disease. Proceedings of a symposium. Kyoto, 27 May 1988.
    Drugs; 1988; 36 Suppl 1():1-151. PubMed ID: 3240720
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists].
    Lüscher TF; Tanner FC; Bühler FR
    Dtsch Med Wochenschr; 1992 Apr; 117(18):710-9. PubMed ID: 1572260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serotonin and its physiological and pathophysiological roles. Ketanserin].
    Metelitsa TV
    Kardiologiia; 1989 Sep; 29(9):120-5. PubMed ID: 2687555
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of serotonin in the regulation of the circulatory system].
    Buczko W
    Pol Tyg Lek; 1985 Apr; 40(16):469-72. PubMed ID: 3160011
    [No Abstract]   [Full Text] [Related]  

  • 7. The rationale for ketanserin therapy in hypertension.
    Hansson L; Hedner T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and cardiovascular regulation: a new approach to hypertension.
    Zanchetti A
    J Hypertens Suppl; 1986 Apr; 4(1):S37-8. PubMed ID: 2939212
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serotoninergic receptors and cardiovascular diseases].
    Hong E; Castillo C; Flores E; Mercedes F
    Gac Med Mex; 1994; 130(3):131-3. PubMed ID: 7657075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symposium on serotonin and cardiovascular regulation: a new approach to hypertension. Satellite symposium of the Second European Meeting on Hypertension. 9 June 1985, Milan, Italy.
    J Hypertens Suppl; 1986 Apr; 4(1):S1-111. PubMed ID: 2939207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of ketanserin--a serotonin antagonist--in the treatment of arterial hypertension].
    Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(3):559-60. PubMed ID: 3576002
    [No Abstract]   [Full Text] [Related]  

  • 12. Serotonin in cardiovascular regulation. Satellite symposium to the 11th International Society of Hypertension meeting. Heidelberg, Federal Republic of Germany, September 6, 1986. Proceedings.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S1-S137. PubMed ID: 2446052
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiological relevance of serotonin.
    van Zwieten PA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S19-25. PubMed ID: 2446063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical significance of serotonin antagonists].
    Regenthal R; Voigt H
    Z Gesamte Inn Med; 1989 Sep; 44(17):504-8. PubMed ID: 2686226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR; Amstein R
    Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous ketanserin on arterial and intracranial pressures in patients with systemic hypertension following intracerebral haemorrhage.
    Kay R; Poon WS; Nicholls MG
    J Hum Hypertens; 1993 Aug; 7(4):369-71. PubMed ID: 8410928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin agonists and antagonists in experimental hypertension.
    Saxena PR; Bolt GR; Dhasmana KM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S12-8. PubMed ID: 2446059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ketanserin. Lowering blood pressure using serotonin antagonists].
    Uhl D
    Med Monatsschr Pharm; 1989 Oct; 12(10):298-301. PubMed ID: 2811738
    [No Abstract]   [Full Text] [Related]  

  • 20. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.